Rational drug discovery: Ellagic acid as a potent dual-target inhibitor against hepatitis C virus genotype 3 (HCV G3) NS3 enzymes
Structure-based virtual screening (SBVS) has served as a popular strategy for rational drug discovery. In this study, we aimed to discover novel benzopyran-based inhibitors that targeted the NS3 enzymes (NS3/4A protease and NS3 helicase) of HCV G3 using a combination of in silico and in vitro approa...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
Wiley
2021
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/26655/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|